Genome Technology's May 2007 cover story looked at new ways of studying single cells. The article showcased researchers using RNAi, DNA sequencing, and protein-protein interaction studies to perturb individual cells. Featured on our cover was Michelle Khine at the University of California, Merced, who was using a microfluidic device she developed as a grad student to deliver everything from drug compounds to DNA into single cells. One of Khine's current research projects, engineering heart and blood vessel tissue, is funded by the California Institute for Regenerative Medicine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.